InterVene
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$5.9m | Series A | ||
$15.0m | Series B | ||
Total Funding | $20.9m |
Recent News about InterVene
EditIntervene-med.com is dedicated to providing innovative and effective therapy for patients suffering from Chronic Venous Insufficiency (CVI) due to deep vein reflux (DVR). Operating in the medical technology sector, the company focuses on developing treatments that alleviate the painful and costly symptoms associated with CVI. Intervene-med.com primarily serves patients and healthcare providers in the United States, targeting a significant market need for advanced venous therapies. The business model revolves around the development and commercialization of proprietary medical devices and treatments, generating revenue through product sales and partnerships with healthcare institutions. By addressing a prevalent and underserved medical condition, Intervene-med.com aims to improve patient outcomes and reduce healthcare costs associated with CVI.
Keywords: Chronic Venous Insufficiency, deep vein reflux, medical technology, venous therapy, healthcare, proprietary devices, patient outcomes, healthcare costs, U.S. market, innovative treatments.